The presented figures refer to specimens received during the designated month.
| Nasal swab specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Staphylococcus aureus | No. | 5 | 0 | 2 | 0 | 4 | 1 | 3 | 1 | 1 | 2 | 0 | 2 |
| Penicillin | 60% | - | 0% | - | 75% | 100% | 67% | 0% | 0% | 50% | - | 100% | |
| Oxacillin [MRSA] |
40% | - | 0% | - | 0% | 100% | 33% | 0% | 0% | 0% | - | 0% | |
| Clindamycin | 0% | - | 0% | - | 50% | 100% | 0% | 0% | 0% | 0% | - | 100% | |
| Erythromycin | 0% | - | 0% | - | 50% | 100% | 0% | 0% | 0% | 0% | - | 100% | |
| Gentamicin | 0% | - | 0% | - | 0% | 0% | 0% | 0% | 0% | 0% | - | 0% | |
| Throat swab specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Beta-haemolytic streptococcus of Lancefield Group A, C & G | No. | 5 | 9 | 4 | 3 | 3 | 10 | 2 | 2 | 5 | 4 | 12 | 7 |
| Penicillin | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| Erythromycin | 20% | 44% | 75% | 100% | 33% | 60% | 50% | 50% | 40% | 0% | 50% | 57% | |
| Sputum specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Streptococcus pneumoniae | No. | 10 | 8 | 11 | 12 | 14 | 17 | 14 | 9 | 14 | 3 | 8 | 6 |
| Penicillin | 20% | 13% | 27% | 8% | 29% | 24% | 29% | 44% | 36% | 67% | 13% | 33% | |
| Erythromycin | 90% | 100% | 91% | 83% | 79% | 88% | 93% | 89% | 93% | 100% | 63% | 100% | |
| Levofloxacin | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| Haemophilus influenzae | No. | 60 | 139 | 236 | 275 | 275 | 201 | 112 | 104 | 88 | 70 | 59 | 69 |
| Ampicillin | 45% | 52% | 49% | 48% | 46% | 49% | 49% | 48% | 47% | 46% | 49% | 51% | |
| Amoxicillin + clavulanic acid | 5% | 14% | 20% | 10% | 10% | 12% | 17% | 13% | 11% | 4% | 12% | 12% | |
| Moraxella catarrhalis | No. | 55 | 62 | 57 | 39 | 44 | 28 | 26 | 23 | 17 | 35 | 60 | 89 |
| BL+ | 96% | 97% | 100% | 100% | 95% | 100% | 96% | 100% | 100% | 100% | 100% | 98% | |
| Urine specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Escherichia coli | No. | 446 | 376 | 452 | 451 | 525 | 568 | 532 | 624 | 532 | 529 | 565 | 517 |
| Ampicillin | 67% | 66% | 70% | 65% | 63% | 66% | 67% | 66% | 67% | 67% | 68% | 68% | |
| Amoxicillin + clavulanic acid | 5% | 5% | 4% | 4% | 5% | 4% | 5% | 5% | 3% | 4% | 4% | 4% | |
| Nalidixic acid | 72% | 71% | 72% | 71% | 67% | 70% | 67% | 69% | 72% | 73% | 71% | 73% | |
| Nitrofurantoin | 1% | 1% | 0% | 1% | 1% | 1% | 0% | 0% | 1% | 1% | 1% | 0% | |
| Co-trimoxazole | 39% | 39% | 35% | 31% | 36% | 36% | 34% | 36% | 37% | 37% | 35% | 35% | |
| Levofloxacin | 35% | 31% | 35% | 32% | 31% | 31% | 28% | 32% | 33% | 33% | 32% | 36% | |
| ESBL+ | 20% | 19% | 15% | 16% | 18% | 19% | 19% | 18% | 18% | 21% | 16% | 18% | |
| Klebsiella pneumoniae^ | No. | 80 | 62 | 75 | 85 | 105 | 86 | 101 | 123 | 124 | 123 | 100 | 76 |
| Amoxicillin + clavulanic acid | 9% | 13% | 7% | 12% | 9% | 8% | 7% | 7% | 12% | 6% | 12% | 4% | |
| Nalidixic acid | 21% | 19% | 23% | 16% | 11% | 16% | 17% | 17% | 26% | 21% | 27% | 18% | |
| Nitrofurantoin | 13% | 23% | 13% | 19% | 21% | 10% | 12% | 11% | 12% | 11% | 14% | 13% | |
| Co-trimoxazole | 25% | 27% | 21% | 20% | 19% | 22% | 19% | 15% | 29% | 16% | 19% | 21% | |
| Levofloxacin | 8% | 11% | 5% | 7% | 5% | 2% | 1% | 2% | 5% | 6% | 8% | 3% | |
| ESBL+ | 14% | 10% | 7% | 9% | 6% | 8% | 15% | 6% | 13% | 10% | 13% | 11% | |
| Proteus mirabilis^^ | No. | 51 | 56 | 55 | 52 | 57 | 71 | 65 | 65 | 49 | 60 | 71 | 52 |
| Ampicillin | 33% | 39% | 40% | 40% | 51% | 46% | 32% | 48% | 53% | 50% | 45% | 33% | |
| Amoxicillin + clavulanic acid | 4% | 4% | 5% | 8% | 9% | 4% | 2% | 6% | 2% | 7% | 3% | 6% | |
| Nalidixic acid | 29% | 38% | 33% | 37% | 35% | 39% | 38% | 37% | 47% | 37% | 38% | 25% | |
| Co-trimoxazole | 29% | 20% | 36% | 31% | 42% | 38% | 35% | 46% | 43% | 42% | 46% | 44% | |
| Levofloxacin | 20% | 25% | 20% | 19% | 19% | 21% | 23% | 23% | 24% | 22% | 21% | 10% | |
| Enteric specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Campylobacter spp. | No. | 1 | 4 | 1 | 3 | 2 | 4 | 2 | 2 | 1 | 2 | 2 | 0 |
| Erythromycin | 0% | 25% | 0% | 33% | 0% | 0% | 0% | 0% | 100% | 0% | 50% | - | |
| Salmonella spp. | No. | 8 | 2 | 3 | 7 | 6 | 9 | 20 | 13 | 12 | 9 | 10 | 5 |
| Ampicillin | 13% | 100% | 67% | 57% | 33% | 22% | 20% | 46% | 58% | 44% | 50% | 40% | |
| Co-trimoxazole | 13% | 50% | 0% | 14% | 33% | 11% | 15% | 0% | 8% | 33% | 20% | 40% | |
| Ciprofloxacin | 13% | 0% | 0% | 0% | 33% | 22% | 0% | 0% | 0% | 0% | 10% | 0% | |
| Shigella spp. | No. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
| Ampicillin | - | - | - | - | - | - | - | 0% | - | 100% | 100% | - | |
| Ciprofloxacin | - | - | - | - | - | - | - | 100% | - | 100% | 100% | - | |
| Vibrio spp. | No. | 0 | 1 | 2 | 3 | 4 | 9 | 8 | 4 | 10 | 4 | 6 | 0 |
| Tetracycline | - | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | - | |
| Soft tissue specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Staphylococcus aureus | No. | 65 | 60 | 74 | 69 | 74 | 94 | 88 | 108 | 97 | 75 | 78 | 70 |
| Oxacillin [MRSA] |
15% | 27% | 27% | 23% | 28% | 21% | 31% | 25% | 27% | 25% | 22% | 9% | |
*Abbreviations:
MRSA = methicillin resistant Staphylococcus aureus
BL+ = beta-lactamse positive
ESBL+ = extended-spectrum beta-lactamase positive
^ Klebsiella pneumoniae is 100% resistant to ampicillin.
^^Proteus mirabilis is 100% resistant to nitrofurantoin.